Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Xanthogranulomatous Pyelonephritis : Article by

Quick Find
Authors & Editors
Introduction
Indications
Relevant Anatomy
Contraindications
Workup
Treatment
Complications
Outcome and Prognosis
Future and Controversies
Multimedia
References




Patient Education
Click here for patient education.



Author: Joe D Mobley III, MD, MPH, Resident Physician, Department of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine/University of Tennessee Medical Center

Joe D Mobley, III, is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, Endourological Society, and Tennessee Medical Association

Coauthor(s): Scott Rutchik, MD, Assistant Professor, Department of Surgery, Division of Urology, University of Connecticut School of Medicine

Editors: Gamal Mostafa Ghoniem, MD, FACS, Fellowship Program Director, Clinical Professor of Surgery, Head, Section of Voiding Dysfunction, Female Urology and Reconstruction, Cleveland Clinic Florida; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center; Bradley Fields Schwartz, DO, FACS, Associate Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Author and Editor Disclosure

Synonyms and related keywords: xanthogranulomatous pyelonephritis, XGP, infectious renal phlegmon, long-term renal obstruction, renal cell carcinoma, nephrectomy, pyelocutaneous fistulae, ureterocutaneous fistulae, pyeloenteric fistulae

Xanthogranulomatous pyelonephritis (XGP) is a rare, serious, debilitating illness characterized by an infectious renal phlegmon. This disease process ultimately results in focal or diffuse renal destruction and is characterized pathologically by lipid-laden foamy macrophages. XGP shares many characteristics with true renal neoplasms in terms of its radiographic appearance and ability to involve adjacent structures or organs. Most cases of XGP are unilateral and are often associated with urinary tract obstruction, infection, nephrolithiasis, diabetes, and/or immunocompromise. The treatment of XGP is almost universally extirpative and can pose a formidable challenge to the surgeon.

History of the Procedure

Schlagenhaufer first described XGP in 1916. The first pediatric case was not described until 1963. Historically, open extirpative therapy has been the hallmark of management, although an increasing number of reports have recently described successful laparoscopic intervention. 

Problem

XGP is defined as a chronic inflammatory disorder of the kidney characterized by a destructive mass that invades the renal parenchyma. The condition is most commonly associated with Proteus or Escherichia coli infection. Pseudomonas species have also been implicated. The kidney is usually nonfunctional. Most cases of XGP involve a diffuse process; however, up to 20% are focal. 

Although most cases of XGP are unilateral, bilateral disease has been reported. Bilateral nephrectomy and long-term dialysis is a treatment option. Although Perez et al described successful treatment with partial nephrectomies in one patient,1 bilateral XGP is usually fatal.

Frequency

XGP occurs in approximately 1% of all renal infections. Although XGP is rare in the pediatric population, it is found in approximately 16% of pediatric nephrectomy specimens. XGP is 4 times more common in women than in men and is usually noted in the fifth and sixth decades of life. XGP affects both kidneys with equal frequency.

Etiology

The exact etiology of XGP is unknown, but it is generally accepted that the disease process requires long-term renal obstruction and infection. Stones (frequently of staghorn proportions) develop in 80% of patients with XGP but are not required to make the diagnosis. XGP is often observed in patients with diabetes and/or immunocompromise. Abnormal lipid metabolism has also been hypothesized as an etiologic factor in individuals with XGP.

Pathophysiology

XGP displays neoplasmlike properties capable of local tissue invasion and destruction and has been referred to as a pseudotumor. Adjacent organs, including the spleen, pancreas, or duodenum, may be involved. 

The gross appearance of XGP is a mass of yellow tissue with regional necrosis and hemorrhage, superficially resembling renal cell carcinoma. The pathognomonic microscopic feature is the lipid-laden foamy macrophage accompanied by both chronic- and acute-phase inflammatory cells. Focal abscesses may be observed.

Clinical

Patients with XGP often appear chronically ill. Symptoms include anorexia, fever, chills, weight loss, and flank pain. The pain of XGP is not colicky in nature; it is usually dull and persistent. Urine typically contains both leukocytes and bacteria. The pH is often basic because Proteus mirabilis is a urease-producing organism. The erythrocyte sedimentation rate is frequently elevated.

XGP is notorious for fistulization. Pyelocutaneous and ureterocutaneous fistulae have been well-described. Other organs are occasionally involved in this process, including surrounding viscera with resulting pyeloenteric fistulae.

In children, XGP is more common in boys and usually affects those younger than 8 years. Obstruction associated with XGP in the pediatric population is more due to congenital factors than obstructive calculi.

Renal cell carcinoma may be indistinguishable from XGP radiographically and clinically. A case of XGP involving thrombus of the renal vein has been reported.2 XGP and renal cell carcinoma have even been observed in the same specimen. Shah et al have reported a mistaken diagnosis of renal XGP that was subsequently proven to be renal tuberculosis.3 XGP must be diagnosed based on histology rather than based solely on radiographic imaging studies.

Illustrating the varied presentation of XGP, a recent case report by Hitti et al describes XGP located in a renal allograft.4 Another recent report describes a case of XGP associated with psoas abscess in a young pregnant woman in her third trimester.5



Xanthogranulomatous pyelonephritis (XGP) is a surgically managed disease requiring either nephrectomy or, in rare circumstances, partial nephrectomy. Extirpation is necessary because the disease occurs or results in an infected, nonfunctioning kidney.



The kidneys are paired organs in the retroperitoneum. They are covered in a thin, fibrous capsule that is in turn covered by Gerota fascia. On the right, the liver and adrenal gland abut the superior pole of the kidney. The second part of the duodenum is medial to the right kidney and may be reflected medially to gain exposure to the inferior vena cava (Kocher maneuver). On the left, the superior pole of the kidney is attached to the spleen superolaterally (splenorenal ligament) and is very near to or in direct contact with the tail of the pancreas medially.

The colon is anterior to the kidneys and is easily reflected anteriorly and medially when transabdominal exposure is required. The renal hilar structure from anterior to posterior includes the vein, artery, and collecting system. The left renal vein has 3 draining tributaries, ie, the adrenal, gonadal, and posterior lumbar veins.



Contraindications to surgical therapy of xanthogranulomatous pyelonephritis (XGP) are those consistent with all major operations and intolerance to anesthesia, uncorrected coagulopathy, and severe connective-tissue disorders. 



Lab Studies

  • CBC count with differential may reveal leukocytosis and anemia. Expect these conditions to gradually resolve after nephrectomy.
  • Liver function findings are abnormal in up to 50% of patients with xanthogranulomatous pyelonephritis (XGP).
  • Serum chemistries are used to determine the presence of any baseline electrolyte abnormalities, although none is pathognomonic of XGP. Creatinine levels prior to nephrectomy may be abnormal, but removal of the nonfunctioning xanthogranulomatous kidney should not be expected to alter baseline renal function.
  • Urinalysis often demonstrates pyuria and proteinuria.
  • Urine cultures are important in determining the offending organism involved in the XGP process and in assisting the appropriate selection of antibiotics.

Imaging Studies

XGP cannot be diagnosed solely based on radiographic findings.

  • CT scanning  
    • CT scanning is the most useful radiographic technique in evaluating XGP.
    • A CT scan demonstrates a heterogenous nonenhancing mass on a hydronephrotic nonfunctioning kidney with a central stone. In higher-stage disease, the mass may appear to involve adjacent organs.
    • A large staghorn calculus may be found within the collecting system.
  • Renal ultrasonography usually reveals an enlarged kidney with multiple hypoechoic masses, irregular thinned parenchyma, and a dilated collecting system.
  • Mercaptotriglycine (MAG-3) or technetium-99m dimercaptosuccinic acid (Tc-DMSA) renal scanning may be used to evaluate or confirm differential renal function.
  • MRI is being studied selectively, but recent reports show little diagnostic benefit of MRI over traditional CT scanning.

Histologic Findings

The pathognomonic microscopic feature is the lipid-laden foamy macrophage. These cells can be difficult to distinguish from clear cell carcinoma on frozen section. 

Staging

Malek and Elder have proposed the following stages of XGP involvement:6

  • Kidney
  • Perinephric fat
  • Adjacent retroperitoneal structures



Medical therapy

Medical therapy has proven sufficient for treatment of xanthogranulomatous pyelonephritis (XGP) in only a handful of cases. Antibiotics may be appropriate as a temporizing measure in patients who require a medical workup prior to nephrectomy. Similarly, appropriate antibiotics should be administered prior to operative intervention.

The choice of antibiotic should be geared toward the identity and sensitivity of the organism. Proteus organisms and E coli are usually sensitive to various antibiotics, including first-generation cephalosporins and trimethoprim-sulfamethoxazole. Pseudomonas species have a narrower spectrum to which they are sensitive, however, and may require the use of aminoglycosides, third-generation cephalosporins, or fluoroquinolones. In patients who are not septic and who have been evaluated on an outpatient basis, the author's preference is to use an oral antibiotic until surgery, when intravenous antibiotics may be administered. Guidelines have not been established regarding the duration of antibiotic therapy after nephrectomy, but the author usually continues an active oral agent for 1 week.

Surgical therapy

Nephrectomy is the criterion standard of treatment for XGP. These are often challenging cases, particularly in patients with local organ involvement. The goal is to remove all involved granulomatous tissue. If this is not accomplished, the remaining infected tissue may lead to cutaneous fistulae.

Some authors have advocated a role for partial nephrectomy if the disease is limited and therefore amenable to this operation.7

Laparoscopic nephrectomy is feasible for certain cases of XGP. Small pediatric series of XGP have reported success with the laparoscopic technique. However, Bercowsky et al reported that the technical difficulty and associated complications of the procedure negated any benefits over open nephrectomy.8 The increased use of hand-assisted laparoscopic nephrectomy may allow for an acceptable compromise between technical feasibility and acceptable patient morbidity. The laparoscopic approach may be entertained in all cases, but the patient and the patient's family can expect a conversion rate of nearly 50%.

Preoperative details

  • Appropriate preoperative imaging studies are essential. This is best accomplished with CT scanning.
  • Administer a bowel preparation and preoperative antibiotics.
  • Surgical consent should include provisions for the possibility of operation on adjacent organs.
  • If the patient is diabetic, establish control of hyperglycemia prior to surgery.
  • Correct any preexisting coagulopathy.

Intraoperative details

A flank approach through the appropriate intercostal/subcostal subcostal space (often the 11th rib) is desirable to avoid contamination of the peritoneum. Transabdominal subcostal exposure may be unavoidable if adjacent organs are involved with the mass.

The basic principles of nephrectomy apply to the extirpation of renal XGP. If possible, a radical nephrectomy (including Gerota fascia) should be performed, since the mass may still represent a neoplasm. All involved tissue must be removed. Liberal irrigation with antibiotic fluid is performed, and a suction drain is left in place.

Postoperative details

The immediate postoperative care for patients with XGP is consistent with care that follows standard nephrectomy.

  • Watch for signs of sepsis.
  • Institute aggressive pulmonary toilet.
  • Encourage early ambulation.

Follow-up

Annual imaging of the contralateral urinary tract is important. Aggressively treat all urinary tract infections. If possible, eliminate or control the agent or illness that is predisposing the patient to XGP. Evaluation of lower urinary tract pathology and voiding dysfunction may be important in these patients.



The urological surgeon should maintain a low threshold to involve a general surgeon in patients with xanthogranulomatous pyelonephritis (XGP). Bleeding should be aggressively controlled. On the left, splenic injury may result; if possible, preservation of the spleen should be attempted. Any pancreatic injuries must be identified, repaired, and appropriately drained.

Similarly, right-sided injuries may occur to the duodenum and liver. Liver lacerations during nephrectomy are frequently limited to capsular tears, which may be easily controlled with argon-beam coagulation and pressure. Duodenal injuries require repair and nasogastric and cutaneous drainage. The colon is vulnerable to injury on either side. A patient who has received adequate bowel preparation may typically have these colonic injuries primarily repaired.

Vascular injury, especially on the right side, that involves the inferior vena cava can be humbling. The right-sided processes are often very inflamed and stuck, involving the adrenal and gonadal veins, lending them to avulsion and injury. Great care must be taken when dissecting out the right renal hilum. An alternative is to cross-clamp the hilum, transect it, and oversew the entire bundle. This can be planned or used in an emergency.

Postoperative abscess and cutaneous fistulization may occur, often after the drain has been removed and the patient has been discharged from the hospital. Patients typically present with drainage from the wound and fevers. CT scanning and percutaneous drainage should be performed, along with administration of intravenous antibiotics.



The overall prognosis for xanthogranulomatous pyelonephritis (XGP) is good. Death from this entity is exceedingly rare, although morbidity is substantial.



  • Nephron-sparing surgery will continue to be explored, provided that viable renal parenchyma is demonstrated.
  • Now that laparoscopic nephrectomy is the criterion standard in many regions, this approach can be entertained depending on the individual surgeon's skill level.
  • Further investigation is necessary to determine the underlying pathophysiologic mechanism responsible for the formation of xanthogranulomatous pyelonephritis (XGP).



Media file 1:  Xanthogranulomatous pyelonephritis (XGP).
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Xanthogranulomatous pyelonephritis (XGP) with obstruction and staghorn calculus
Click to see larger pictureClick to see detailView Full Size Image
Media type:  CT

Media file 3:  Xanthogranulomatous pyelonephritis (XGP) appearing as enhancing loculated mass
Click to see larger pictureClick to see detailView Full Size Image
Media type:  CT



  1. Peréz LM, Thrasher JB, Anderson EE. Successful management of bilateral xanthogranulomatous pyelonephritis by bilateral partial nephrectomy. J Urol. Jan 1993;149(1):100-2. [Medline].
  2. Tiguert R, Gheiler EL, Yousif R, Tefilli MV, Mills K, Grignon DJ, et al. Focal xanthogranulomatous pyelonephritis presenting as a renal tumor with vena caval thrombus. J Urol. Jul 1998;160(1):117-8. [Medline].
  3. Shah HN, Jain P, Chibber PJ. Renal tuberculosis simulating xanthogranulomatous pyelonephritis with contagious hepatic involvement. Int J Urol. Jan 2006;13(1):67-8. [Medline].
  4. Hitti W, Drachenberg C, Cooper M, Schweitzer E, Cangro C, Klassen D, et al. Xanthogranulomatous pyelonephritis in a renal allograft associated with xanthogranulomatous diverticulitis: report of the first case and review of the literature. Nephrol Dial Transplant. Nov 2007;22(11):3344-7. [Medline].
  5. Loffroy R, Guiu B, Varbédian O, Michel F, Sagot P, Cercueil JP. Diffuse xanthogranulomatous pyelonephritis with psoas abscess in a pregnant woman. Can J Urol. Apr 2007;14(2):3507-9. [Medline].
  6. Malek RS, Elder JS. Xanthogranulomatous pyelonephritis: a critical analysis of 26 cases and of the literature. J Urol. May 1978;119(5):589-93. [Medline].
  7. Osca JM, Peiro MJ, Rodrigo M, Martinez-Jabaloyas JM, Jimenez-Cruz JF. Focal xanthogranulomatous pyelonephritis: partial nephrectomy as definitive treatment. Eur Urol. 1997;32(3):375-9. [Medline].
  8. Bercowsky E, Shalhav AL, Portis A, Elbahnasy AM, McDougall EM, Clayman RV. Is the laparoscopic approach justified in patients with xanthogranulomatous pyelonephritis?. Urology. Sep 1999;54(3):437-42; discussion 442-3. [Medline].
  9. Borum ML. An unusual case of nephrobronchial and nephrocolonic fistula complicating xanthogranulomatous pyelonephritis. Urology. Sep 1997;50(3):443. [Medline].
  10. Borzi PA, Yeung CK. Selective approach for transperitoneal and extraperitoneal endoscopic nephrectomy in children. J Urol. Feb 2004;171(2 Pt 1):814-6; discussion 816. [Medline].
  11. Bottalico T, Parks S, Zaslau S, Tarry WF. Pediatric xanthogranulomatous pyelonephritis masquerading as complex renal mass. Urology. Aug 2007;70(2):372.e11-2. [Medline].
  12. Eastham J, Ahlering T, Skinner E. Xanthogranulomatous pyelonephritis: clinical findings and surgical considerations. Urology. Mar 1994;43(3):295-9. [Medline].
  13. Loffroy R, Guiu B, Watfa J, Michel F, Cercueil JP, Krause D. Xanthogranulomatous pyelonephritis in adults: clinical and radiological findings in diffuse and focal forms. Clin Radiol. Sep 2007;62(9):884-90. [Medline].
  14. Marteinsson VT, Due J, Aagenaes I. Focal xanthogranulomatous pyelonephritis presenting as renal tumour in children. Case report with a review of the literature. Scand J Urol Nephrol. Jun 1996;30(3):235-9. [Medline].
  15. Matthews GJ, McLorie GA, Churchill BA, Steckler RE, Khoury AE. Xanthogranulomatous pyelonephritis in pediatric patients. J Urol. Jun 1995;153(6):1958-9. [Medline].
  16. Nataluk EA, McCullough DL, Scharling EO. Xanthogranulomatous pyelonephritis, the gatekeeper's dilemma: a contemporary look at an old problem. Urology. Mar 1995;45(3):377-80. [Medline].
  17. Papadopoulos I, Wirth B, Wand H. Xanthogranulomatous pyelonephritis associated with renal cell carcinoma. Report on two cases and review of the literature. Eur Urol. 1990;18(1):74-6. [Medline].
  18. Tan YH, Siddiqui K, Preminger GM, Albala DM. Hand-assisted laparoscopic nephrectomy for inflammatory renal conditions. J Endourol. Oct 2004;18(8):770-4. [Medline].
  19. Toprak U, Erdogan A, Gulbay M, Karademir MA, Pasaoglu E, Akar OE. Preoperative evaluation of renal anatomy and renal masses with helical CT, 3D-CT and 3D-CT angiography. Diagn Interv Radiol. Mar 2005;11(1):35-40. [Medline].
  20. Tunc L, Biri H, Onaran M, Krac M, Yesil S, Bozkirli I. Laparoscopic nephrectomy for xanthogranulomatous pyelonephritis in the absence of kidney stones or clinical urinary infection. Surg Laparosc Endosc Percutan Tech. Dec 2007;17(6):570-2. [Medline].

Xanthogranulomatous Pyelonephritis excerpt

Article Last Updated: Jun 11, 2008